Skip to main content
Signal8

Disbrow Jarrett

SEC insider (Form 3/4/5 filer). CIK 0001640724. Chief Business Officer at AYTU BIOPHARMA, INC (AYTU). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in DENVER, CO.

Companies Disbrow Jarrett has filed insider reports for

  • AYTU BIOPHARMA, INC (AYTU): Officer, Chief Business Officer
Disbrow Jarrett profile photo

Disbrow Jarrett

CIK: 0001640724

Transaction Breakdown

Open Market Buys (P)1 (20.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AYTU BIOPHARMA, INC logo
AYTU

AYTU BIOPHARMA, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Jul 28, 2026
    Award
    Direct
    15K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Oct 3, 2025
    Award
    Direct
    19.6K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Oct 3, 2025
    Award
    Direct
    12.5K shares-
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Jun 9, 2025
    Purchase
    Direct
    16.7K shares at avg. $1.50$25K
  • AYTU BIOPHARMA, INC logo
    AYTU

    AYTU BIOPHARMA, INC

    Nov 6, 2024
    Award

    Employee Stock Option (Right to Buy)

    Direct
    7K shares-

1-5 of 5